Skip to main content

CDSCO Clarifies Export NOC Requirements for Approved r-DNA Products

The Central Drugs Standard Control Organization (CDSCO) has issued a clarification stating that pharmaceutical companies may not need a separate Export No Objection Certificate (NOC) for certain already approved recombinant DNA (r-DNA) drug products intended for export.
Mankind Pharma to Invest 48 Million euro in Belgian Biotech Firm for 70% Stake, Enters Next-Generation CAR-T Therapy Market
Mankind Pharma to Invest 48 Million euro in Belgian Biotech Firm for 70% Stake, Enters Next-Generation CAR-T Therapy Market
Mankind Pharma Limited has entered into a definitive agreement to acquire a 70% stake in Armed Cell Therapeutics B.V. (ACTx), a Belgium-incorporated biotechnology company developing next-generation chimeric antigen receptor T-cell (CAR-T) therapies for cancer.
USFDA Expands Anktiva Approval to High-Grade Papillary Bladder Cancer After BCG Treatment Failure
USFDA Expands Anktiva Approval to High-Grade Papillary Bladder Cancer After BCG Treatment Failure
The US Food and Drug Administration (FDA) has expanded the approved use of Anktiva (nogapendekin alfa inbakicept-pmln), in combination with Bacillus Calmette-Guérin (BCG), to include adults with high-grade papillary-only non-muscle-invasive bladder cancer that has not responded to BCG treatment.
Lilly’s Omvoh Shows Promising One-Year Disease Control Results in Ulcerative Colitis and Crohn’s Disease
Lilly’s Omvoh Shows Promising One-Year Disease Control Results in Ulcerative Colitis and Crohn’s Disease
Eli Lilly and Company has announced new analyses of clinical trial data showing that its drug Omvoh (mirikizumab-mrkz) helped some patients with moderately to severely active ulcerative colitis and Crohn’s disease achieve multiple treatment goals simultaneously at one year.
Reserve Bank of India invites Pharmacists - 22 Openings
Reserve Bank of India invites Pharmacists - 22 Openings
Matriculation or its equivalent examination. Applicant should possess minimum qualification of Diploma in Pharmacy from recognized University registered under Pharmacy Act, 1948.
Government Pharmacist Opportunity under District Health & Family Welfare Samiti - 23 posts
Government Pharmacist Opportunity under District Health & Family Welfare Samiti - 23 posts

Birbhum District Health & Family Welfare Samiti will engage personnel for various positions as listed below under National Health Mission. Department of Health and Family Welfare, Government of West Bengal purely on contractual basis.

Post : Pharmacist 

Recruitment for Pharmacists (15 posts) under Health & Family Welfare Department
Recruitment for Pharmacists (15 posts) under Health & Family Welfare Department
The candidate should have a two-year Diploma in Pharmacy (D-Pharma) (ALLOPATHIC) from any institute approved by the Pharmacy Council of India.
Career for Pharma and Science candidates as Research Manager at NIPER
Career for Pharma and Science candidates as Research Manager at NIPER
MSc / MPharm from recognised University / Institute. experience in research/teaching/industry and established reputation of having made conspicuous seminal contribution to knowledge in Pharmaceutical and allied areas. Central Instrumentation Facility, Centre of Excellence, NIPER-Guwahati
Opportunity for Pharmacy Professionals to Join ICMR-NIRDH | Salary Rs 1,25,000/- month
Opportunity for Pharmacy Professionals to Join ICMR-NIRDH | Salary Rs 1,25,000/- month
Professionals having proven competency and success in their area of specialization, with post-qualification experience and should possess minimum M.Sc/B.Tech/B.E. in Biomedical Sciences, Biomedical Engineering, Health Informatics or equivalent degree in relevant subjects.
Pharmacists Interview : 08 posts in Pediatric and Adult Haematolymphoid Unit, BBCI
Pharmacists Interview : 08 posts in Pediatric and Adult Haematolymphoid Unit, BBCI
B.Pharm OR D.Pharm Registration with State Pharmacy Council with dully allotted Registration Number is mandatory.